Post
Aspira Women’s Health introduces OvaWatch to assess ovarian cancer risk
OvaWatch evaluates the risk of ovarian cancer for women with adnexal masses.
Health Canada approves Novocure’s Optune to treat glioblastoma
Optune uses four adhesive patches to provide TTFields therapy to the tumour location.
Boston Scientific to acquire Apollo Endosurgery for $615m
The deal is intended to expand Boston Scientific’s endoluminal surgery portfolio.
GE Healthcare and MediView partner to develop OmnifyXR solution
The new partnership intends to advance precision care using remote collaboration and evidence-based insights.
Halo and Ikonopedia partner to provide genetic testing for breast cancer
The integration is expected to lead to a 40% increase in compliance for follow-up imaging.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Smartphone-based diagnosis to promote the early detection of chronic diseases
The field of mHealth has experienced exponential growth in recent years.
NeuroLogica receives FDA 510(k) clearance for new BodyTom 64 scanner
The new BodyTom 64 scanner has been designed to improve clinical workflows and boost user experience.
Neurology medical devices could expand indications to treat sports-related head injuries
Preliminary studies suggest that neuromodulation devices could be used to treat CTE and sports-related traumatic brain injuries.
CHUV, CERN and THERYQ partner to develop cancer radiotherapy device
The new device will use very high-energy electron radiation to treat cancers that are resistant to conventional treatments.
Brainomix and Pixyl partner to offer multiple sclerosis solution
Neuro.MS is intended for the diagnosis and treatment of multiple sclerosis patients.
Boston Scientific reports initial data from ACURATE neo2 system study
Another observation from the study was a low 6.5% rate of new pacemaker implantation 30 days after procedures.
